Trials / Unknown
UnknownNCT03071198
Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy
Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy for T3-4N0-2M0 Middle and Lower Rectal Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (estimated)
- Sponsor
- Harbin Medical University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Clinical effect of neoadjuvant hierarchical treatment based on chemotherapy for T3-4N0-2M0 middle and lower rectal cancer
Detailed description
By setting 3-Year disease-free survival (DFS) as main objective, the treatment strategy will be optimizing as neoadjuvant chemotherapy alone and chemo-radio-chemo sequential treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | TME | 1. Find the hypogastric nerve trunk in front of sacral promontory and protect it,be careful to use electrocautery hemostasis biased toward the side of rectal when handle lateral ligament of rectum and middle rectal artery and avoid to damage the pelvic plexus. 2. At least a 2-cm margin to the lower edge of the tumor is adequate for distal bowel resection. Resect 5cm length distal rectal or all of the mesorectum.Check the integrity of the mesorectum in postoperative routine examination. Double stapling method is used for all low anastomosis operations. |
| RADIATION | Concurrent chemo-radiotherapy | Three-dimensional conformal radiotherapy as following: CTV 44Gy/22 times+GTV1 6Gy/3 times(2Gy/time/day,5 days a week,totally 5 weeks),if rectal tumors do not regress obviously, additional GTV2 is necessary, 5.4Gy/3 times (1.8Gy/time/day). At the same time, Capecitabine (850mg/m2, two times every day) will be taken on radiotherapy day |
| DRUG | neoadjuvant CT | CAPEOX protocol:Oxaliplatin 130mg/m2 ivgtt 2-6h dl;(Capecitabine 1000mg/m2 2 times a day lasts for 14 days Repeat every 3 weeks |
| DRUG | adjuvant CT | CAPEOX protocol:Oxaliplatin 130mg/m2 ivgtt 2-6h dl;(Capecitabine 1000mg/m2 2 times a day lasts for 14 days Repeat every 3 weeks |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2018-09-30
- Completion
- 2021-09-30
- First posted
- 2017-03-06
- Last updated
- 2017-03-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03071198. Inclusion in this directory is not an endorsement.